EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Evaluation of the efficacy, safety and satisfaction rates of platelet‐rich plasma, non‐cross‐linked hyaluronic acid and the combination of platelet‐rich plasma and non‐cross‐linked hyaluronic acid in patients with burn scars treated with fractional CO 2 laser: A randomized controlled clinical trial

Masoumeh Roohaninasab, Alireza Jafarzadeh iD, Afsaneh Sadeghzadeh-Bazargan, Sona Zare, Maryam Nouri, Mohammad Ali Nilforoushzadeh iD, Elham Behrangi iD

International Wound Journal · 2024

DOI: 10.1111/iwj.70065 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Wound Journal, 2024. Verfasst von Masoumeh Roohaninasab und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical …. Hauptthemen laut MEDLINE: Burns, Cicatrix, Hyaluronic Acid, Lasers, Gas. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skin scarring can result from burns, injuries, stretch marks and acne, leading to cosmetic and functional difficulties. Treatments for burn scars encompass a range of options, such as lasers, corticosteroid injections, surgery and regenerative techniques such as platelet‐rich plasma (PRP). Hyaluronic acid‐based products offer skin hydration and shield against aging effects. A study is being conducted to evaluate how effective PRP injection, hyaluronic acid and their combination improve burn scars and their effects on quality of life and potential disabilities. In our study, PRP and non‐cross‐linked hyaluronic acid treatments were compared in 10 individuals with burn scars between 2022 and 2023. Patients received CO 2 fractional laser treatment followed by injections in scar areas. Evaluations included the Vancouver scar scale (VSS), biometric assessments, ultrasounds and satisfaction ratings. Two therapy sessions were conducted at 1‐month interval, and assessments were done before treatment, 1 month after the first session, and 3 months after the first session. Biometric assessments showed significant improvements in various parameters (tewametry, corneometry, erythema index, melanin index, cutometry, thickness and density) in the intervention groups compared to the placebo group ( p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BurnsCicatrixHyaluronic AcidLasers, GasPatient SatisfactionPlatelet-Rich PlasmaAdultFemaleHumansMaleMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

PRPRCTatrophic scarburn scarclinical trialnon‐cross‐linked hyaluronic acidplatelet‐rich plasmascar

Substanzen

Hyaluronic Acid

Autor:innen und Institutionen

  • Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
  • Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Stem Cell and Regenerative Medicine Institute, Sharif University of Technology, Tehran, Iran.
  • Department of Mechanical Engineering, Sharif University of Technology, Tehran, Iran.
  • Skin Repair Research Center, Jordan Dermatology and Hair Transplantation Center, Tehran, Iran.

ORCID-Profile: Alireza Jafarzadeh, Mohammad Ali Nilforoushzadeh, Elham Behrangi

Zitieren

APA

Roohaninasab, M., Jafarzadeh, A., Sadeghzadeh-Bazargan, A., Zare, S., Nouri, M., Nilforoushzadeh, M. A., & Behrangi, E. (2024). Evaluation of the efficacy, safety and satisfaction rates of platelet‐rich plasma, non‐cross‐linked hyaluronic acid and the combination of platelet‐rich plasma and non‐cross‐linked hyaluronic acid in patients with burn scars treated with fractional CO 2 laser: A randomized controlled clinical trial. International Wound Journal. https://doi.org/10.1111/iwj.70065

Vancouver

Roohaninasab M, Jafarzadeh A, Sadeghzadeh-Bazargan A, Zare S, Nouri M, Nilforoushzadeh MA, et al. Evaluation of the efficacy, safety and satisfaction rates of platelet‐rich plasma, non‐cross‐linked hyaluronic acid and the combination of platelet‐rich plasma and non‐cross‐linked hyaluronic acid in patients with burn scars treated with fractional CO 2 laser: A randomized controlled clinical trial. International Wound Journal. 2024. doi:10.1111/iwj.70065

BibTeX
@article{Roohaninasab2024,
  author = {Roohaninasab, Masoumeh and Jafarzadeh, Alireza and Sadeghzadeh-Bazargan, Afsaneh and Zare, Sona and Nouri, Maryam and Nilforoushzadeh, Mohammad Ali and Behrangi, Elham},
  title = {Evaluation of the efficacy, safety and satisfaction rates of platelet‐rich plasma, non‐cross‐linked hyaluronic acid and the combination of platelet‐rich plasma and non‐cross‐linked hyaluronic acid in patients with burn scars treated with fractional CO 2 laser: A randomized controlled clinical trial},
  journal = {International Wound Journal},
  year = {2024},
  doi = {10.1111/iwj.70065}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche